Table of Contents Author Guidelines Submit a Manuscript
Critical Care Research and Practice
Volume 2011, Article ID 594645, 6 pages
http://dx.doi.org/10.1155/2011/594645
Research Article

In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between Sepsis and SIRS than CRP, Il-6, or LBP

1Intensive Care Unit of the Reinier de Graaf Groep, Reinier de Graafweg 3-11, 2625AD Delft, The Netherlands
2Department of Medical Immunology of the Reinier de Graaf Groep, Reinier de Graafweg 3-11, 2625AD Delft, The Netherlands
3Department of Microbiology of the Reinier de Graaf Groep, Reinier de Graafweg 3-11, 2625AD Delft, The Netherlands

Received 25 November 2010; Revised 21 February 2011; Accepted 18 March 2011

Academic Editor: Clifford Scott Deutschman

Copyright © 2011 Iwan A. Meynaar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. C. Bone, R. A. Balk, F. B. Cerra et al., “Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis,” Chest, vol. 101, no. 6, pp. 1644–1655, 1992. View at Google Scholar
  2. R. P. Dellinger, M. M. Levy, J. M. Carlet et al., “Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008,” Critical Care Medicine, vol. 36, no. 1, pp. 296–327, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. C. Pierrakos and J.-L. Vincent, “Sepsis biomarkers: a review,” Critical Care, vol. 14, no. 1, article R15, 2010. View at Publisher · View at Google Scholar · View at PubMed
  4. F. M. Brunkhorst, K. Wegscheider, Z. F. Forycki, and R. Brunkhorst, “Procalcitonin for early diagnosis and differentation of SIRS, sepsis, severe sepsis, and septic shock,” Intensive Care Medicine, vol. 26, no. 2, pp. S148–S152, 2000. View at Google Scholar · View at Scopus
  5. C. Clec'h, F. Ferriere, P. Karoubi et al., “Diagnostic and prognostic value of procalcitonin in patients with septic shock,” Critical Care Medicine, vol. 32, no. 5, pp. 1166–1169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. B. M. Tang, G. D. Eslick, J. C. Craig, and A. S. McLean, “Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis,” Lancet Infectious Diseases, vol. 7, no. 3, pp. 210–217, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. B. Uzzan, R. Cohen, P. Nicolas, M. Cucherat, and G. Y. Perret, “Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis,” Critical Care Medicine, vol. 34, no. 7, pp. 1996–2003, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. K. Reinhart, M. Meisner, and F. M. Brunkhorst, “Markers for sepsis diagnosis: what is useful?” Critical Care Clinics, vol. 22, no. 3, pp. 503–519, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. L. Blairon, X. Wittebole, and P. F. Laterre, “Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections,” Journal of Infectious Diseases, vol. 187, no. 2, pp. 287–291, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. P. J. Erwin, H. Lewis, S. Dolan et al., “Lipopolysaccharide binding protein in acute pancreatitis,” Critical Care Medicine, vol. 28, no. 1, pp. 104–109, 2000. View at Google Scholar · View at Scopus
  11. C. E. Ventetuolo and M. M. Levy, “Biomarkers: diagnosis and risk assessment in sepsis,” Clinics in Chest Medicine, vol. 29, no. 4, pp. 591–603, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. A. S. Glas, J. G. Lijmer, M. H. Prins, G. J. Bonsel, and P. M. M. Bossuyt, “The diagnostic odds ratio: a single indicator of test performance,” Journal of Clinical Epidemiology, vol. 56, no. 11, pp. 1129–1135, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. M. S. Pepe, H. Janes, G. Longton, W. Leisenring, and P. Newcomb, “Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker,” American Journal of Epidemiology, vol. 159, no. 9, pp. 882–890, 2004. View at Publisher · View at Google Scholar
  14. P. Kopterides, I. I. Siempos, I. Tsangaris, A. Tsantes, and A. Armaganidis, “Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials,” Critical Care Medicine, vol. 38, no. 11, pp. 2229–2241, 2010. View at Publisher · View at Google Scholar · View at PubMed